Regener-Eyes Ophthalmic Solution Professional

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of burning and irritation due to dryness of the eye. It serves as a lubricant to prevent further irritation and to alleviate dryness of the eye. Additionally, this product acts as a protectant against further irritation and is specifically formulated to provide temporary relief from symptoms associated with dry eyes.

Each formulation is preservative-free, making it suitable for frequent use as a protective measure against eye dryness and irritation.

No teratogenic or nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals are advised to instill 1 or 2 drops of the medication in the affected eye(s) as needed. The frequency of administration should be determined based on the clinical condition of the patient and the response to treatment. It is important to ensure that the drops are administered in a sterile manner to prevent contamination.

Contraindications

There are no contraindications associated with the use of this product. It is not classified as a controlled substance, and there are no known risks of abuse, misuse, or dependence. Therefore, no specific conditions or situations have been identified in which the product should not be used.

Warnings and Precautions

External use only. To prevent contamination, it is imperative that the tip of the container does not come into contact with any surface. The cap should be securely replaced after each use. Should the solution change color or become cloudy, it must not be used.

Healthcare professionals should advise patients to discontinue use and seek medical attention if they experience any of the following symptoms: eye pain, changes in vision, persistent redness, or irritation of the eye. If the condition worsens or does not improve within 72 hours, further evaluation by a physician is necessary.

This product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Side Effects

Patients should be aware of the potential adverse reactions associated with the use of this product. Serious reactions may necessitate immediate medical attention. Patients are advised to discontinue use and consult a healthcare professional if they experience eye pain, changes in vision, continued redness, or irritation of the eye. Additionally, if the condition worsens or persists for more than 72 hours, medical advice should be sought.

It is important to note that this product is for external use only. To prevent contamination, patients should avoid touching the tip of the container to any surface and ensure the cap is replaced after each use. If the solution changes color or becomes cloudy, it should not be used.

Furthermore, this product should be kept out of reach of children. In the event of accidental ingestion, patients should seek medical help or contact a Poison Control Center immediately.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Regener-Eyes Ophthalmic Solution Professional (glycerin ophthalmic solution). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is no specific information available regarding the use of Regener-Eyes Ophthalmic Solution during pregnancy. Consequently, the safety concerns, dosage modifications, or special precautions related to its use in pregnant patients have not been established. Healthcare professionals should weigh the potential benefits against any unknown risks when considering the use of this product in women of childbearing potential. It is advisable to monitor for any adverse effects and to counsel patients accordingly.

Lactation

There are no specific warnings or recommendations regarding the use of Regener-Eyes Ophthalmic Solution in lactating mothers. Additionally, there is no information available concerning the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the lack of specific guidance necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, it is imperative to seek immediate medical assistance. If the substance is ingested, healthcare professionals should be contacted without delay, or the individual should reach out to a Poison Control Center for guidance.

Prompt intervention is crucial to mitigate potential adverse effects associated with overdosage. Healthcare providers are advised to monitor the patient closely for any symptoms that may arise and to initiate appropriate management procedures based on the clinical presentation.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

No postmarketing experience details are available in the provided text.

Patient Counseling

Healthcare providers should encourage patients to reach out with any questions or concerns they may have regarding their treatment. It is important for patients to feel comfortable discussing their health and any issues that may arise. Providers can direct patients to contact the dedicated support line at (656) 225-2260 for assistance. This resource is available to ensure that patients receive the information and support they need throughout their treatment journey.

Storage and Handling

The product is supplied in a container that must be stored at room temperature. To maintain the integrity of the solution, it is essential to avoid contamination; therefore, the tip of the container should not come into contact with any surfaces. After each use, the cap should be securely replaced to prevent exposure to environmental factors.

In the event that the solution changes color or becomes cloudy, it should not be used and must be discarded. Additionally, the product should be discarded after opening to ensure safety and efficacy.

Additional Clinical Information

Patients and clinicians are encouraged to reach out with any questions regarding the medication by contacting the provided helpline at (656) 225-2260.

Drug Information (PDF)

This file contains official product information for Regener-Eyes Ophthalmic Solution Professional, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)